XML 48 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2020
Stock-Based Compensation Expense The following table presents stock-based compensation expense in the Company’s consolidated statements of comprehensive income:
                 
 
Three Months Ended
March 31,
 
 
2020
 
 
2019
 
 
(Amounts in thousands)
 
Cost of product revenue
  $
433
    $
324
 
Research and development
   
372
     
321
 
Selling, general and administrative
   
3,360
     
2,606
 
                 
Total stock-based compensation
  $
4,165
    $
3,251
 
                 
 
 
Summary of Option Activity
Information regarding option activity for the three months ended March 31, 2020 under the Plans is summarized below:
                                 
 
Shares
 
 
Weighted
average
exercise
price
 
 
Weighted-
Average
Remaining
Contractual
Term
(in Years)
 
 
Aggregate
Intrinsic Value
(in Thousands)
 
Options outstanding at December 31, 2019
   
957,559
    $
30.81
     
     
 
Granted
   
25,836
    $
86.10
     
     
 
Exercised
   
(67,877
)   $
23.56
     
     
 
Forfeited/expired/cancelled
   
—  
    $
—  
     
     
 
                                 
Options outstanding at March 31, 2020
   
915,518
    $
32.91
     
6.64
    $
58,257
 
                                 
Options exercisable at March 31, 2020
   
555,159
    $
26.77
     
5.65
    $
38,734
 
                                 
Vested and expected to vest at March 31, 2020
(1)
   
885,461
     
     
6.59
    $
56,522
 
                                 
 
 
 
 
 
 
(1) Represents the number of vested options as of March 31, 2020 plus the number of unvested options expected to vest as of March 31, 2020 based on the unvested outstanding options at March 31, 2020 adjusted for estimated forfeiture rates of 8% for awards granted to
non-executive
level employees and 3% for awards granted to executive level employees.
 
 
Summary of Restricted Stock Unit Activity
The fair value of stock units is calculated using the closing price of the Company’s common stock on the date of grant. Information regarding stock unit activity, which includes activity for restricted stock units and performance stock units, for the three months ended March 31, 2020 under the Plans is summarized below:
                         
 
Shares
 
 
Weighted-
Average
Remaining
Contractual
Term
(in Years)
 
 
Aggregate
Intrinsic Value
(in Thousands)
 
Unvested at December 31, 2019
   
734,984
     
     
 
Awarded
   
127,286
     
     
 
Vested
   
(132,053
)    
     
 
Forfeited/expired/cancelled
   
(13,587
)    
     
 
                         
Unvested at March 31, 2020
   
716,630
     
3.69
    $
69,183
 
                         
Vested and expected to vest at March 31, 2020
(1)
   
656,225
     
3.43
    $
63,352
 
                         
 
 
 
 
 
(1) Represents the number of vested stock units as of March 31, 2020 plus the number of unvested stock units expected to vest as of December 31, 2019 based on the unvested outstanding stock units at December 31, 2019 adjusted for estimated forfeiture rates of 8% for awards granted to
non-executive
level employees and 3% for awards granted to executive level employees.